Category Archives: BioUtah News
The University of Utah and RenalytixAI Partner to Drive Innovation in Kidney Health
Utah’s RenalytixAI and the University of Utah last week announced a partnership to improve kidney health and reduce the risk of kidney failure for large scale populations in the earliest stages of kidney disease. The partnership intends to implement RenalytixAI’s in vitro diagnostic platform, KidneyIntelX, in combination with a range of advanced clinical management solutions […]
2021 BioHive Entrepreneur and Investor Life Sciences Summit BioHive, J.P. Morgan, Pitch Competition, Local, National Investors and More…
ICYMI If you missed the 2021 BioHive Entrepreneur and Investor Life Sciences (E&I) Summit or weren’t able to attend all the sessions, you can access the programming for a limited time. Registered attendees can access recorded sessions free of charge. Not already registered? You can register and access the program for $25. The 2021 E&I […]
BioUtah Hosts LIfe Sciences Roundtable with Congressional Healthcare Leaders
BioUtah recently held a life sciences industry roundtable with Republican lawmakers in the U.S. House of Representatives who play a key role in shaping healthcare policy around the FDA, CMS, NIH and more. Lawmakers included our own Rep. John Curtis (R-UT) who now sits on the House Energy and Commerce (E&C) Committee and Subcommittee on […]
American Society of Nephrology and Renalytix Co-Host Virtual Capital Markets Day for Kidney Health
RenalytixAI co-hosted a Capital Markets Day for Kidney Health with the American Society of Nephrology yesterday, Feb. 11. The virtual event brought together a broad group of delegates representing the kidney community, including leading clinicians, representatives of U.S. government health agencies, kidney care innovators and investors focused on life sciences and medical technology, for a […]
Attostat is now EVŌQ Nano – Seeks Next Round of Investment Following Antimicrobial Efficacy Studies
Attostat is now EVŌQ Nano! The Utah start-up has a new name, a clean look and a fresh website. Following years of scientific research and development, EVŌQ Nano is ready to share its story of next-generation nanotechnology and raise its next round of investment. “We truly are a thought leader in nanotechnology,” said CEO Scott […]
Novel Embolic Device Used for Arterial and Venous Tumor Treatments
Fluidx Medical Technology has announced successful patient use of the GPX Embolic Device to therapeutically devascularize, or block blood supply to, a tumor. The GPX Embolic Device is an innovative embolic designed to combine the benefits of other embolics like coils, particles, and liquids with simplified preparation, delivery, precision, and control leading to durable, long-term […]
MAYOR ERIN MENDENHALL’S SALT LAKE CITY 2021 PLAN INCLUDES BIOHIVE
Last week, Salt Lake City (SLC) Mayor Erin Mendenhall gave her second State of the City address – a live broadcast from the City Council Chambers in which she reflected on 2020 and outlined her plan for the City in 2021. The Mayor noted that “we are striving to make our city better through change; […]
Spectrum Solutions Collaborates with UCLA on Saliva-Based Next-Gen Sequencing (NGS) Liquid Biopsy Research for the Early Detection of Lung Cancer
Spectrum Solutions, LLC on January 27 announced it is sponsoring research in collaboration with the UCLA School of Dentistry for a study on using saliva in early lung cancer detection and analysis. Spectrum has funded a study that aims to recruit 50 patients with lung cancer and seeks to validate saliva’s tumor-specific ctDNA detection sensitivity […]
Entrepreneur Your Startup – Get a Master’s Degree
Calling all life sciences early stage founders and startups! In partnership with the Lassonde Entrepreneur Institute at the University of Utah, the University’s David Eccles School of Business is now accepting applications to join its Master of Business Creation (MBC) program for 2021-2022. The priority application deadline is Feb. 12, 2021. This nine-month, professional-degree program […]
SDP Oncology Announces First Patient Dosed in Phase 1/2 Study of TP-0184 for the Treatment of Anemia in Patients with Low or Intermediate Risk Myelodysplastic Syndromes
Lehi-based Sumitomo Dainippon Pharma Oncology (SDP Oncology) recently announced that the first patient has been dosed in a Phase 1/2 study evaluating the investigational agent TP-0184, an activin receptor-like kinase 2 (ALK2) and ALK5 inhibitor, for the treatment of anemia in adult patients with low or intermediate risk myelodysplastic syndromes (MDS). “The management of […]
Science and Safety of the COVID-19 Vaccine (January 15, 2021)
Presented by BioUtah and the Salt Lake Chamber on January 15, 2021, this webinar provided a briefing with biopharmaceutical industry experts to discuss the science behind the development of COVID-19 vaccines, the regulatory process to ensure they’re safe and effective and an update on Utah’s participation in COVID-19 clinical trials.
Co-Diagnostics Anticipates Reporting Highest Quarterly Revenue Following Demand for COVID-19 Diagnostic Products
Based on its preliminary internal financial reporting for the fourth quarter 2020, Co-Diagnostics has announced that unaudited quarterly revenue for the company is anticipated to be the highest in the company’s history and to surpass analyst estimates. Analysts’ estimates for the fourth quarter ranged from $24 million to $25.98 million. Quarterly revenue is anticipated to […]
